DIA
JAZZ icon

Dean Investment Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dean Investment Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
42,633
+718
+2% +$157K 1.35% 2
2026
Q1 		$7.92M Buy
41,915
+968
+2% +$169K 1.12% 12
2025
Q4 		$6.96M Buy
40,947
+898
+2% +$138K 0.99% 14
2025
Q3 		$5.28M Buy
40,049
+2,459
+7% +$295K 0.74% 36
2025
Q2 		$3.99M Buy
37,590
+7,180
+24% +$780K 0.59% 62
2025
Q1 		$3.78M Buy
30,410
+1,959
+7% +$256K 0.56% 64
2024
Q4 		$3.5M Buy
28,451
+3,753
+15% +$442K 0.5% 73
2024
Q3 		$2.75M Sell
24,698
-778
-3% -$85.3K 0.37% 136
2024
Q2 		$2.72M Buy
25,476
+7,602
+43% +$836K 0.39% 119
2024
Q1 		$2.15M Buy
17,874
+864
+5% +$106K 0.3% 139
2023
Q4 		$2.09M Buy
17,010
+232
+1% +$29K 0.3% 137
2023
Q3 		$2.17M Buy
16,778
+7,214
+75% +$961K 0.36% 107
2023
Q2 		$1.19M Buy
+9,564
New +$1.29M 0.19% 180
2018
Q4 		– Sell
-5,387
Closed -$906K – 219
2018
Q3 		$906K Buy
5,387
+119
+2% +$20.5K 0.13% 170
2018
Q2 		$908K Buy
5,268
+76
+1% +$12.4K 0.13% 155
2018
Q1 		$784K Buy
+5,192
New +$762K 0.12% 169
2015
Q3 		– Sell
-2,494
Closed -$439K – 226
2015
Q2 		$439K Hold
2,494
– – 0.1% 216
2015
Q1 		$431K Buy
+2,494
New +$428K 0.1% 205

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dean Investment Associates's JAZZ Position: Q2 2026 in Review

Dean Investment Associates increased its Jazz Pharmaceuticals (JAZZ) stake by 1.7% in Q2 2026, buying an estimated $157K and bringing the position to 42,633 shares worth $10.3M. The position accounts for 1.35% of the portfolio, ranked #2.

Dean Investment Associates first reported a position in JAZZ in Q1 2015 and has held it in 18 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Dean Investment Associates held 42,633 shares of Jazz Pharmaceuticals worth $10.3M as of Q2 2026.
  • Dean Investment Associates bought 718 Jazz Pharmaceuticals shares in Q2 2026, an estimated $157K.
  • Jazz Pharmaceuticals made up 1.35% of Dean Investment Associates's portfolio in Q2 2026, its #2 holding.
  • Dean Investment Associates first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 18 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.